Jonathan Spero Promoted to Vice President
NEW YORK, N.Y., May 22, 2019-- BelHealth Investment Partners, LLC (“BelHealth”), a healthcare-focused private equity firm, today announced that Jonathan Spero has been promoted to Vice President. Mr. Spero previously served as Senior Associate and Associate. He has been with BelHealth since 2015.
During his tenure at BelHealth, Mr. Spero has contributed to the firm in many ways including origination and structuring to due diligence, execution and portfolio company monitoring. He has supported the Fund II portfolio since inception and currently works with Village Fertility Pharmacy and Care Advantage. Jon also works directly with several Fund I portfolio companies.
Mr. Spero has more than six years of experience working with healthcare services, products and distribution companies. Previously, he worked as an analyst in the healthcare investment banking division of SunTrust Robinson Humphrey where he focused on M&A, equity and leveraged finance transactions. He began his career at Schneider Downs Corporate Finance, a boutique investment bank focused on lower middle market M&A. Mr. Spero received his Bachelor of Science in Business Administration from Carnegie Mellon University.
Inder Tallur, Senior Managing Director of BelHealth, said, "Jon has been a dedicated member of the BelHealth team for more than four years and it is great to see him advance in his career. He has worked hard to develop a well-rounded skill set and is very deserving of this promotion. He will remain a key member of the team and is ready for increased responsibility as we move into the future at BelHealth.”
About BelHealth Investment Partners
BelHealth Investment Partners, based in New York, New York, is a healthcare private equity firm focused on lower middle market companies. BelHealth has a unique combination of investing, executive management and entrepreneurial experience. BelHealth acquires majority positions in entrepreneur-owned companies that it believes will benefit from its extensive operating and private equity investment expertise. The firm invests across three core healthcare segments: Services, Products and Distribution. BelHealth is investing from its current $350 million fund.
For further information, please visit:
BelHealth Investment Partners: www.belhealth.com
Inder Tallur: firstname.lastname@example.org; (347) 308-7018
Venture Capital Database